Surfactant for pulmonary haemorrhage in neonates

Cochrane Database of Systematic Reviews

Volumn 2020, Issue 2, 2020, Pages

  Aziz, Abdul ^a   Ohlsson, Arne ^b  

^a William Osler Health Centre   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; LUNG SURFACTANT;

ASSISTED VENTILATION; BLOOD CLOTTING DISORDER; FETUS GROWTH; GESTATIONAL AGE; HUMAN; INTRATRACHEAL DRUG ADMINISTRATION; INTRAUTERINE GROWTH RETARDATION; LUNG BLOOD FLOW; LUNG HEMORRHAGE; MENARCHE; META ANALYSIS; NEWBORN; NEWBORN MORTALITY; PATENT DUCTUS ARTERIOSUS; PREMATURE LABOR; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME; BLEEDING; LUNG DISEASE; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

HEMORRHAGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG DISEASES; PULMONARY SURFACTANTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85078957100     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005254.pub4     Document Type: Review

References (36)

1. Lacaze-Masmonteil T. Expanded use of surfactant therapy in newborns. Clinics in Perinatology 2007;34:179-89. x-wiley/crsRef/12748482
2. Abdel-Latif ME, Osborn DA. Nebulised surfactant for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD008310]
3. Abdel-Latif ME, Osborn DA. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD008309.pub2]
4. Abdel-Latif ME, Osborn DA. Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD008311.pub2]
5. Amizuka T, Shimizu H, Niida Y, Ogawa Y. Surfactant therapy in neonates with respiratory failure due to haemorrhagic pulmonary oedema. European Journal of Pediatrics 2003;162:697-702.
6. Cole VA, Normand IC, Reynolds EO, Rivers RP. Pathogenesis of hemorrhagic pulmonary edema and massive pulmonary hemorrhage in the newborn. Pediatrics 1973;51:175-87.
7. Dargaville PA, Mills JF, Soll R. Therapeutic lung lavage for meconium aspiration syndrome in newborn infants. Cochrane Database of Systematic Reviews 2002, Issue 1. [DOI: 10.1002/14651858.CD003486]
8. El Shahed AI, Dargaville P, Ohlsson A, Soll RF. Surfactant for meconium aspiration syndrome in full term/near term infants. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD002054.pub2]
9. Findlay RD, Taeusch HW, David-Cu R, Walther FJ. Lysis of red blood cells and alveolar epithelial toxicity by therapeutic pulmonary surfactants. Pediatric Research 1995;37:26-30.
10. Finer NN. Surfactant use for neonatal lung injury: beyond respiratory distress syndrome. Paediatric Respiratory Reviews 2004;5:Suppl A:S289-97.
11. Haas NA, Kulasekaran K, Camphausen CK. Successful use of surfactant to treat severe intrapulmonary hemorrhage after iatrogenic lung injury - a case report. Pediatric Critical Care Medicine 2006;7:583-5.
12. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org 2011.
13. Holm BA, Notter RH. Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity. Journal of Applied Physiology 1987;63:1434-42.
14. Pandit PB, Dunn MS, Colucci EA. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage. Pediatrics 1995;95:32-6.
15. Pandit PB, O'Brien K, Asztalos E, Colucci E. Dunn MS. Outcome following pulmonary haemorrhage in very low birthweight neonates treated with surfactant. Archives of Disease in Childhood. Fetal and Neonatal Edition 1999;81:F40-4.
16. Pappin A, Shenker N, Hack M, Redline RW. Extensive intraalveolar pulmonary hemorrhage in infants dying after surfactant therapy. Journal of Pediatrics 1994;124:621-6.
17. Papworth S, Cartlidge PHT. Pulmonary haemorrhage. Current Paediatrics 2001;11:167-71.
18. Pfister RH, Soll R, Wiswell TE. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD006069.pub3]
19. Pfister RH, Soll R, Wiswell TE. Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD006180.pub2]
20. Raju TN, Langenberg P. Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis. Journal of Pediatrics 1993;123:603-10.
21. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
22. Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD000510.pub2]
23. Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD007836]
24. Sinclair J, Bracken M. Effective Care of the Newborn. Oxford University Press, 1992.
25. Singh N, Hawley KL, Viswanathan K. Efficacy of porcine versus bovine surfactants for preterm newborns with respiratory distress syndrome: systematic review and meta-analysis. Pediatrics 2011; Vol. 128:e1588-95.
26. Soll RF, Ozek E. Prophylactic animal derived surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 1997, Issue 4. [DOI: 10.1002/14651858.CD000511]
27. Soll RF. Synthetic surfactant for respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews 1998, Issue 3. [DOI: 10.1002/14651858.CD001149]
28. Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database of Systematic Reviews 1999, Issue 4. [DOI: 10.1002/14651858.CD001456]
29. Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD000144]
30. Soll R, Ozek E. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD000141.pub2]
31. Soll R, Ozek E. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD001079.pub2]
32. Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD003063.pub3]
33. Tan K, Lai NM, Sharma A. Surfactant for bacterial pneumonia in late preterm and term infants. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD008155.pub2]
34. Van Houten J, Long W, Mullett M, Finer N, Derleth D, McMurray B, et al. Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. Journal of Pediatrics 1992;120:S40-4.
35. Wiswell TE. Expanded uses of surfactant therapy. Clinics in Perinatology 2001;28:695-711.
36. Aziz A, Ohlsson A. Surfactant for pulmonary hemorrhage in neonates. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD005254.pub2]